Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Iron deficiency anaemia
Anthony Lopez1, Patrice Cacoub2, Iain C Macdougall3
1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
Insights
Iron deficiency anaemia affects a third of the global population, impacting maternal and child health. Newer diagnostic methods and intravenous iron treatments offer safe and effective management strategies for this widespread condition.
Area of Science:
- Hematology
- Public Health
- Nutritional Science
Background:
- Iron deficiency anaemia (IDA) is a significant global health issue, affecting approximately one-third of the world's population.
- It disproportionately impacts vulnerable groups, including young children (0-5 years), women of childbearing age, and pregnant women.
- IDA is frequently comorbid with chronic conditions such as chronic kidney disease, heart failure, cancer, and inflammatory bowel disease.
Purpose of the Study:
- To provide a comprehensive overview of iron deficiency anaemia.
- To discuss current diagnostic approaches, treatment strategies, and future research directions.
Main Methods:
- Review of clinical presentation, epidemiology, and pathophysiology of IDA.
- Evaluation of diagnostic accuracy of various biomarkers, including serum ferritin and transferrin saturation.
- Assessment of current and emerging treatment modalities, encompassing oral iron, intravenous iron, and hepcidin-based therapies.
Main Results:
- Advanced diagnostic markers like serum ferritin and transferrin saturation offer superior accuracy over traditional red cell indices for IDA diagnosis.
- Intravenous iron formulations provide a safe and effective alternative for replenishing iron stores.
- Hepcidin emerges as a crucial regulator of iron homeostasis with potential diagnostic and therapeutic applications.
Conclusions:
- Iron deficiency anaemia remains a critical global health challenge requiring multifaceted management strategies.
- Accurate diagnosis through advanced biomarkers and effective treatment with modern iron formulations are essential.
- Further research into hepcidin's role may unlock novel therapeutic targets for IDA.
Abstract:
Anaemia affects roughly a third of the world's population; half the cases are due to iron deficiency. It is a major and global public health problem that affects maternal and child mortality, physical performance, and referral to health-care professionals. Children aged 0-5 years, women of childbearing age, and pregnant women are particularly at risk. Several chronic diseases are frequently associated with iron deficiency anaemia--notably chronic kidney disease, chronic heart failure, cancer, and inflammatory bowel disease. Measurement of serum ferritin, transferrin saturation, serum soluble transferrin receptors, and the serum soluble transferrin receptors-ferritin index are more accurate than classic red cell indices in the diagnosis of iron deficiency anaemia. In addition to the search for and treatment of the cause of iron deficiency, treatment strategies encompass prevention, including food fortification and iron supplementation. Oral iron is usually recommended as first-line therapy, but the most recent intravenous iron formulations, which have been available for nearly a decade, seem to replenish iron stores safely and effectively. Hepcidin has a key role in iron homoeostasis and could be a future diagnostic and therapeutic target. In this Seminar, we discuss the clinical presentation, epidemiology, pathophysiology, diagnosis, and acute management of iron deficiency anaemia, and outstanding research questions for treatment.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
The Periodic Table and Organismal Elements
Erythropoiesis
Microbes and Other Elemental Cycles
The Early Endosome: Endocytosis of Transferrin

